HF/Transplantation

Top Story

TRED-HF: HF therapy withdrawal after cardiomyopathy recovery increases relapse risk

TRED-HF: HF therapy withdrawal after cardiomyopathy recovery increases relapse risk
November 11, 2018

Read the Perspective from James L. Januzzi Jr., MD

Meeting NewsPerspective

PIONEER-HF: Sacubitril/valsartan superior to enalapril in acute decompensated HF

November 11, 2018
CHICAGO — Patients with acute decompensated HF had greater reduction in N-terminal pro-B-type natriuretic peptide when assigned sacubitril/valsartan than treatment…
Meeting NewsPerspective

Thrill-seeking activities relatively safe for hypertrophic cardiomyopathy

November 11, 2018
CHICAGO — Patients with hypertrophic cardiomyopathy who participate in thrill-seeking activities such as roller coasters and jet skiing after a diagnosis had mild…
Meeting NewsPerspective

DECLARE-TIMI 58: Dapagliflozin reduces HF hospitalization in type 2 diabetes

November 10, 2018
CHICAGO — The DECLARE-TIMI 58 trial of dapagliflozin in patients with type 2 diabetes who had or were at high risk for atherosclerotic CVD adds to the growing body…
More Headlines »
CME

Providing Quality Care for Patients with Heart Failure

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Heart failure (HF) affects as many as 6 million adults in the United States, and the prevalence is anticipated to
More »
Video
Meeting News Coverage

VIDEO: Plenary session moderator discusses advancements in pluripotent stem cell research

September 22, 2016
More »
Video
Meeting News

VIDEO: 'Incredible amount of science' presented at ESC Congress

October 7, 2018
More »